Similar articles

• Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine, and metergoline.

  Arosio M, Moriondo P, Travaglini P, Ambrosi B, Beck-Peccoz P, Puglisi FC, Secchi F, Faglia G. Arosio M, et al. J Clin Endocrinol Metab. 1980 Sep;51(3):454-61. doi: 10.1210/jcem-51-3-454. J Clin Endocrinol Metab. 1980. PMID: 6773973 No abstract available.
• Effects of thyroliberin (TRH), bromocriptine and cyproheptadine on somatotropin secretion in acromegaly.

  Pawlikowski M, Strejczek H, Owczarczyk I, Komorowski J. Pawlikowski M, et al. Mater Med Pol. 1980 Jan-Jun;12(1-2):70-3. Mater Med Pol. 1980. PMID: 6799708 No abstract available.
• Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.

  Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Hizuka N, Takano K, Wakabayashi I, Demura H, Ling N, et al. Shibasaki T, et al. J Clin Endocrinol Metab. 1986 Jul;63(1):167-73. doi: 10.1210/jcem-63-1-167. J Clin Endocrinol Metab. 1986. PMID: 2872226
• Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.

  Giustina G, Reschini E, Peracchi M, Cantalamessa L, Cavagnini F, Pinto M, Bulgheroni P. Giustina G, et al. J Clin Endocrinol Metab. 1974 May;38(5):906-9. doi: 10.1210/jcem-38-5-906. J Clin Endocrinol Metab. 1974. PMID: 4207370 No abstract available.
• Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.

  Benker G, Zäh W, Hackenberg K, Hamburger B, Günnewig H, Reinwein D. Benker G, et al. Horm Metab Res. 1976 Jul;8(4):291-5. doi: 10.1055/s-0028-1093638. Horm Metab Res. 1976. PMID: 182633